DV
Dividend Vision

RGEN — Repligen Corporation

Repligen Corporation (RGEN)

Its deepest 1-year drawdown was 40.3%.

RGEN is an equity stock that appears to be a single company holding rather than a diversified ETF fund. Repligen Corporation operates as a biotechnology equipment and services provider, and the security does not currently distribute dividends, making it unsuitable for income-focused dividend strategies. This holding appeals primarily to growth-oriented investors seeking exposure to the life sciences sector rather than those targeting regular dividend income.

RGEN key facts

Asset type
Stock
Asset class
Equity
Inception date
04/29/1986
Distribution frequency
None
Last close
$166.83
Market cap
$9,415,154,688
Average volume
598100.0
Beta
1.012
Payout ratio
0.0
P/E ratio
225.4459
Forward P/E
79.3651
EPS
$0.74